Annual EBITDA
$6.68B$1.67B+33.39%
Summary
- Current Value
- As of today, MCK annual EBITDA is $6.68B, up +33.39% on
- Historical Performance
- MCK annual EBITDA is up +25.80% over the past 3 years, up +41.20% over the past 5 years
- All-Time High Comparison
- MCK annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- MCK annual EBITDA is +46.43% above its 3-year low of $4.56B reached on
- Sector Comparison
- MCK annual EBITDA is higher than 97.96% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $6.68B | +33.4% | +25.8% | +41.2% | +157.5% | |
| Quarterly EBITDA | $1.99B | +24.6% | +88.2% | +111.2% | +168.2% | |
| TTM EBITDA | $7.87B | +44.4% | +59.9% | +69.0% | +188.0% | |
| Price | $1,069.43 | +25.9% | +136.1% | +384.1% | +1236.6% | |
| PE Ratio | 27.50 | +4.0% | +53.5% | – | +55.7% | |
| Annual Revenue | $403.43B | +12.4% | +45.8% | +69.3% | +259.9% | |
| Annual EPS | $38.37 | +49.2% | +53.3% | +235.8% | +793.1% | |
| Annual EBIT | $5.95B | +36.1% | +33.6% | +69.5% | +183.7% | |
| Annual Net Income | $5.10B | +46.5% | +36.9% | +217.5% | +351.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $6.68B | at high | |
| 5Y | $6.68B | at high | |
| All | $6.68B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.56B | +46.4% | |
| 5Y | $3.72B | +79.4% | |
| All | $39.70M | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of MCK?
- As of today, MCK annual EBITDA is $6.68B
- What is 1-year change in MCK annual EBITDA?
- MCK annual EBITDA is up +33.39% year-over-year
- What is 3-year change in MCK annual EBITDA?
- MCK annual EBITDA is up +25.80% over the past 3 years
- How far is MCK annual EBITDA from its all-time high?
- MCK annual EBITDA is currently at its all-time high
- How does MCK annual EBITDA rank versus sector peers?
- MCK annual EBITDA is higher than 97.96% of companies in Healthcare sector
- When is MCK next annual earnings release?
- As of today, the next annual earnings release for MCK has not been scheduled
EBITDA Formula
Quarterly EBITDA
$1.99B$369.00M+22.83%
Summary
- Current Value
- As of today, MCK quarterly EBITDA is $1.99B, up +22.83% on
- Historical Performance
- MCK quarterly EBITDA is up +24.61% year-over-year, up +88.15% over the past 3 years
- All-Time High Comparison
- MCK quarterly EBITDA is currently -38.84% below its historical high of $3.25B set on
- 3-Year Low Comparison
- MCK quarterly EBITDA is +153.84% above its 3-year low of $782.00M reached on
- Sector Comparison
- MCK quarterly EBITDA is higher than 97.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.99B | +22.8% | +24.6% | +88.2% | +111.2% | |
| Annual EBITDA | $6.68B | – | +33.4% | +25.8% | +41.2% | |
| TTM EBITDA | $7.87B | +5.2% | +44.4% | +59.9% | +69.0% | |
| Price | $1,069.43 | +27.5% | +25.9% | +136.1% | +384.1% | |
| PE Ratio | 27.50 | +22.6% | +4.0% | +53.5% | – | |
| Quarterly Revenue | $110.96B | +5.3% | +7.6% | +43.7% | +66.7% | |
| Quarterly EPS | $10.44 | +102.6% | +17.0% | +111.9% | +509.0% | |
| Quarterly EBIT | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Net Income | $1.30B | +25.6% | +11.4% | +84.3% | +318.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.44B | -18.8% | |
| 3Y | $2.44B | -18.8% | |
| 5Y | $2.44B | -18.8% | |
| All | $3.25B | -38.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.59B | N/A | +24.6% |
| 3Y | $782.00M | +153.8% | |
| 5Y | $554.00M | +258.3% | |
| All | -$216.20M | +1018.1% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of MCK?
- As of today, MCK quarterly EBITDA is $1.99B
- What is MCK quarterly EBITDA most recent change?
- MCK quarterly EBITDA was up +22.83% on September 30, 2026
- What is 1-year change in MCK quarterly EBITDA?
- MCK quarterly EBITDA is up +24.61% year-over-year
- How far is MCK quarterly EBITDA from its all-time high?
- MCK quarterly EBITDA is currently -38.84% below its historical high of $3.25B set on June 30, 1994
- How does MCK quarterly EBITDA rank versus sector peers?
- MCK quarterly EBITDA is higher than 97.69% of companies in Healthcare sector
- When is MCK next earnings release?
- The next earnings release for MCK is on
EBITDA Formula
TTM EBITDA
$7.87B$392.00M+5.24%
Summary
- Current Value
- As of today, MCK TTM EBITDA is $7.87B, up +5.24% on
- Historical Performance
- MCK TTM EBITDA is up +44.41% year-over-year, up +59.89% over the past 3 years
- All-Time High Comparison
- MCK TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- MCK TTM EBITDA is +80.61% above its 3-year low of $4.36B reached on
- Sector Comparison
- MCK TTM EBITDA is higher than 97.88% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $7.87B | +5.2% | +44.4% | +59.9% | +69.0% | |
| Annual EBITDA | $6.68B | – | +33.4% | +25.8% | +41.2% | |
| Quarterly EBITDA | $1.99B | +22.8% | +24.6% | +88.2% | +111.2% | |
| Price | $1,069.43 | +27.5% | +25.9% | +136.1% | +384.1% | |
| PE Ratio | 27.50 | +22.6% | +4.0% | +53.5% | – | |
| TTM Revenue | $418.79B | +1.9% | +8.2% | +43.9% | +66.8% | |
| TTM EPS | $38.88 | +4.0% | +21.1% | +53.7% | +229.2% | |
| TTM EBIT | $5.31B | -20.9% | +10.5% | +27.1% | +52.3% | |
| TTM Net Income | $5.43B | +2.5% | +28.5% | +49.0% | +217.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.87B | at high | |
| 3Y | $7.87B | at high | |
| 5Y | $7.87B | at high | |
| All | $7.87B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.45B | N/A | +44.4% |
| 3Y | $4.36B | +80.6% | |
| 5Y | $3.59B | +119.1% | |
| All | $68.40M | >+9999.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of MCK?
- As of today, MCK TTM EBITDA is $7.87B
- What is MCK TTM EBITDA most recent change?
- MCK TTM EBITDA was up +5.24% on September 30, 2026
- What is 1-year change in MCK TTM EBITDA?
- MCK TTM EBITDA is up +44.41% year-over-year
- How far is MCK TTM EBITDA from its all-time high?
- MCK TTM EBITDA is currently at its all-time high
- How does MCK TTM EBITDA rank versus sector peers?
- MCK TTM EBITDA is higher than 97.88% of companies in Healthcare sector
- When is MCK next earnings release?
- The next earnings release for MCK is on
EBITDA Formula
Data Sources & References
- MCK Official Website www.mckesson.com
- MCK Profile on Yahoo Finance finance.yahoo.com/quote/MCK
- MCK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mck
